[1]高悠水 施慧鹏 李晓林 张长青.老年肌肉减少症与脆性骨折的研究进展[J].中华老年骨科与康复电子杂志,2015,(02):48-52.[doi:10.3877/cma.j.issn.2096-0263.2015.02 .009]
点击复制

老年肌肉减少症与脆性骨折的研究进展()
分享到:

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2015年02期
页码:
48-52
栏目:
综述
出版日期:
2015-11-05

文章信息/Info

作者:
高悠水 施慧鹏 李晓林 张长青
上海交通大学附属第六人民医院骨科
DOI:
10.3877/cma.j.issn.2096-0263.2015.02 .009

参考文献/References:

1 Santilli V, Bernetti A, Mangone M, et al. Clinical definition of sarcopenia [J]. Clin Cases Miner Bone Metab, 2014, 11(3): 177-180. 2 Oliveira A, Vaz C. The role of sarcopenia in the risk of osteoporotic hip fracture [J]. Clin Rheumatol, 2015, 34(10): 1673-1680. 3 Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People [J]. Age Ageing, 2010, 39(4): 412-423. 4 Wen X, Wang M, Jiang CM, et al. Are current definitions of sarcopenia applicable for older Chinese adults? [J]. J Nutr Health Aging, 2011, 15(10): 847-851. 5 Morley JE, Anker SD, Von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiologyupdate 2014 [J]. J Cachexia Sarcopenia Muscle, 2014, 5(4): 253-259. 6 Batsis JA, Mackenzie TA, Barre LK, et al. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III [J]. Eur J Clin Nutr, 2014, 68(9): 1001-1007. 7 夏维波. 老年人肌少症的诊断和防治 [J]. 老年医学与保健, 2015, 21(1): 6-9. 8 Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia: definitions and outcome parameters [J]. Osteoporos Int, 2012, 23(7): 1839-1848. 9 Scott D, Daly RM, Sanders KM, et al. Fall and fracture risk in sarcopenia and dynapenia with and without obesity: the role of lifestyle interventions [J]. Curr Osteoporos Rep, 2015, 13(4): 235-244. 10 Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group [J]. N Engl J Med, 1991, 324(19): 1326-1331. 11 洪维, 朱晓颖, 程群, 等. 老年髋部骨折患者肌肉减少症与骨密度 的关系 [J]. 中华骨质疏松和骨矿盐疾病杂志, 2014, 7(2): 106-112. 12 Pereira FB, Leite AF, De Paula AP. Relationship between presarcopenia, sarcopenia and bone mineral density in elderly men [J]. Arch Endocrinol Metab, 2015, 59(1): 59-65. 13 Cederholm T, Cruz-Jentoft AJ, Maggi S. Sarcopenia and fragility fractures [J]. Eur J Phys Rehabil Med, 2013, 49(1): 111-117. 14 Tarantino U, Piccirilli E, Fantini M, et al. Sarcopenia and fragility fractures: molecular and clinical evidence of the bone-muscle interaction [J]. J Bone Joint Surg Am, 2015, 97(5): 429-437. 15 Thornell LE. Sarcopenic obesity: satellite cells in the aging muscle [J]. Curr Opin Clin Nutr Metab Care, 2011, 14(1): 22-27. 16 Basualto-Alarcón C, Varela D, Duran J, et al. Sarcopenia and androgens: a Link between pathology and treatment [J]. Front Endocrinol (Lausanne), 2014, 5: 217. 17 王蓉, 范利, 胡亦新. 肌肉减少症与炎性细胞因子的研究进展 [J]. 中华保健医学杂志, 2014, 16(6): 491-492, 496. 18 Glass DJ. Signaling pathways perturbing muscle mass [J]. Curr Opin Clin Nutr Metab Care, 2010, 13(3): 225-229. 19 Gielen E, Verschueren S, O'neill TW, et al. Musculoskeletal frailty: a geriatric syndrome at the core of fracture occurrence in older age [J]. Calcif Tissue Int, 2012, 91(3): 161-177. 20 Fairchild B, Webb TP, Xiang Q, et al. Sarcopenia and frailty in elderly trauma patients [J]. World J Surg, 2015, 39(2): 373-379. 21 Terracciano C, Celi M, Lecce D, et al. Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis [J]. Osteoporos Int, 2013, 24(3): 1095-1100. 22 Boirie Y. Physiopathological mechanism of sarcopenia [J]. J Nutr Health Aging, 2009, 13(8): 717-723. 23 Kaji H. Linkage between muscle and bone: common catabolic signals resulting in osteoporosis and sarcopenia [J]. Curr Opin Clin Nutr Metab Care, 2013, 16(3): 272-277. 24 Huang J, Hsu YH, Mo C, et al. METTL21C is a potential pleiotropic gene for osteoporosis and sarcopenia acting through the modulation of the NF-κB signaling pathway [J]. J Bone Miner Res, 2014, 29(7): 1531-1540. 25 González-Montalvo JI, Alarcón T, Gotor P, et al. Prevalence of sarcopenia in acute hip fracture patients and its influence on short-term clinical outcome [J]. Geriatr Gerontol Int, 2015, In press. 26 Sj?blom S, Suuronen J, Rikkonen T, et al. Relationship between postmenopausal osteoporosis and the components of clinical sarcopenia [J]. Maturitas, 2013, 75(2): 175-180. 27 Hida T, Shimokata H, Sakai Y, et al. Sarcopenia and sarcopenic leg as potential risk factors for acute osteoporotic vertebral fracture among older women [J]. Eur Spine J, 2015 , In press. 28 Yu R, Leung J, Woo J. Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: results from the Osteoporotic Fractures in Men (MrOs) Study [J]. J Am Med Dir Assoc, 2014, 15(8): 551-558. 29 Di Monaco M, Castiglioni C, Vallero F, et al. Sarcopenia is more prevalent in men than in women after hip fracture: a cross-sectional study of 591 inpatients [J]. Arch Gerontol Geriatr, 2012, 55(2): e48-e52. 30 Di Monaco M, Castiglioni C, De Toma E, et al. Presarcopenia and sarcopenia in hip-fracture women: prevalence and association with ability to function in activities of daily living [J]. Aging Clin Exp Res, 2015, 27(4): 465-472. 31 Di Monaco M, Vallero F, Di Monaco R, et al. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture [J]. Arch Gerontol Geriatr, 2010, 52(1): 71-74. 32 Chalhoub D, Cawthon PM, Ensrud KE, et al. Risk of nonspine fractures in older adults with sarcopenia, low bone mass, or both [J]. J Am Geriatr Soc, 2015, 63(9): 1733-1740. 33 Christie J. Progressive resistance strength training for improving physical function in older adults [J]. Int J Older People Nurs, 2011,6(3): 244-246. 34 Tieland M, Van De Rest O, Dirks ML, et al. Protein supplementation improves physical performance in frail elderly People: a randomized, double-blind, placebo-controlled trial [J]. J Am Med Dir Assoc, 2012, 13(8): 720-726. 35 刘洁, 许红霞. 肌肉减少症的蛋白质补充 [J/CD]. 肿瘤代谢与营养 电子杂志, 2014, 1(3): 10-13. 36 Rieu I, Balage M, Sornet C, et al. Leucine supplementation improves muscle protein synthesis in elderly men independently of hyperaminoacidaemia [J]. J Physiol, 2006, 575(Pt 1): 305-315. 37 Morley JE, Argiles JM, Evans WJ, et al. Nutritional recommendations for the management of sarcopenia [J]. J Am Med Dir Assoc, 2010, 11(6): 391-396. 38 Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a metaanalysis of randomised controlled trials [J]. BMJ, 2009, 339(1): b3692. 39 Bischoff-Ferrari HA. Relevance of vitamin D in muscle health [J]. Rev Endocr Metab Disord, 2012, 13(1): 71-77. 40 Pojednic RM, Ceglia L. The emerging biomolecular role of vitamin D in skeletal muscle [J]. Exerc Sport Sci Rev, 2014, 42(2): 76-81. 41 Beaudart C, Rizzoli R, Bruyère O, et al. Sarcopenia: burden and challenges for public health [J]. Arch Public Health, 2014, 72(1): 45. 42 Urano T, Inoue S. Recent genetic discoveries in osteoporosis, sarcopenia and obesity [J]. Endocr J, 2015, 62(6): 475-484. 43 Hida T, Harada A, Imagama S, et al. Managing sarcopenia and its related-fractures to improve quality of Life in geriatric populations [J]. Aging Dis, 2014, 5(4): 226-237. 44 Mclean RR, Kiel DP. Developing consensus criteria for sarcopenia: an update [J]. J Bone Miner Res, 2015, 30(4): 588-592. 45 Cesari M, Fielding RA, Pahor M, et al. Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia [J]. J Cachexia Sarcopenia Muscle, 2012, 3(3): 181- 190. 46 Watanabe S, Sato K, Hasegawa N, et al. Serum C1q as a novel biomarker of sarcopenia in older adults [J]. FASEB J, 2015, 29(3): 1003-1010. 47 杜艳萍, 朱汉民. 肌少症的诊疗和防治研究 [J]. 中华骨质疏松和骨 矿盐疾病杂志, 2014, 7(1): 1-8. 48 Cheng Q, Zhu X, Zhang X, et al. A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women: reference values, prevalence, and association with bone mass [J]. J Bone Miner Metab, 2014, 32(1): 78-88. 49 Kim S, Won CW, Kim BS, et al. The association between the low muscle mass and osteoporosis in elderly Korean People [J]. J Korean Med Sci, 2014, 29(7): 995-1000. 50 Pongchaiyakul C, Limpawattana P, Kotruchin P, et al. Prevalence of sarcopenia and associated factors among Thai population [J]. J Bone Miner Metab, 2013, 31(3): 346-350. 51 Miyakoshi N, Hongo M, Mizutani Y, et al. Prevalence of sarcopenia in Japanese women with osteopenia and osteoporosis [J]. J Bone Miner Metab, 2013, 31(5): 556-561. 52 Patil R, Uusi-Rasi K, Pasanen M, et al. Sarcopenia and osteopenia among 70-80-year-old home-dwelling Finnish women: prevalence and association with functional performance [J]. Osteoporos Int, 2013, 24(3): 787-796. 53 邱贵兴. 老年骨质疏松性骨折的治疗策略 [J/CD]. 中华老年骨科与 康复电子杂志, 2015, 1(1): 1-5.

更新日期/Last Update: 2015-12-30